Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: Does in vitro metronidazole resistance have any clinical relevance?

American Journal of Gastroenterology

Volumn 92, Issue 2, 1997, Pages 248-253

  Lerang, F ^a   Moum, B ^b   Haug, J B ^b   Tolas P ^b   Breder, O ^b   Aubert, E ^b   Hoie O ^b   Soberg T ^b   Flaaten, B ^b   Farup, P ^b   Berge, T ^b  

^a Østfold Hospital   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; DRUG SCREENING; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ULCER HEALING;

ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; NORWAY; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PENICILLINS; PROSPECTIVE STUDIES; STOMACH ULCER;

EID: 0031050777     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chiba N, Rao BV, Radaemaker JW, et al. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
2. Penston JG. Helicobacter pylori eradication: Understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994;8:369-89.
3. Wilhelmsen I, Weberg R, Berstad K, et al. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease. Hepato-Gastroenterology 1994;41: 43-7.
4. Tytgat GJN. Review Article: Treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-68.
5. Grahams DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
6. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993;88:505-9.
7. de Boer WA, Tytgat GN. The best therapy for Helicobacter pylori infection: Should efficacy or side-effect profile determine our choice? Scand J Gastroenterol 1995;30:401-7.
8. Bazzoli F, Zagari RM, Fossi S, et al. Short-term low-dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-7.
9. Labenz J, Stolte M, Ruhl GH, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995;7:9-11.
10. Jaup BH, Norrby A. Low-dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995;90:943-5.
11. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al. The MACH 1 study: Optimal one-week treatment for H. pylori defined? Gut 1995; 37(suppl 2):A4.
12. Bell GD, Powell KU, Burridge SM, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:41-6.
13. Xia H, Buckley M, Hyde D, et al. Effects of antibiotic resistance on claritromycin-combined triple therapy for Helicobacter pylori. Gut 1995;37(suppl 2):A55.
14. Powell KU, Bell GD, Bowden AF, et al. An effective one-week Helicobacter pylori eradication therapy using omeprazole, claritromycin and metronidazole. Br J Clin Res 1995;6:85-90.
15. Moayyedi P, Sahay P, Tompkins DS, et al. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7:835-40.
16. Moayyedi P, Tompkins DS, Mapstone N, et al. Relevance of antibiotic sensitivities in predicting failure of omeprazole, claritromycin and tinidazole to eradicate Helicobacter pylori. Gut 1996;38(suppl 1): T152.
17. Dal Bo N, Grasso GA, Pilotto A, et al. Claritromycin for the cure of Helicobacter pylori (H. pylori) infection. Gut 1994;35(suppl 5.1):W64.
18. Thillainayagam AV, Arvind AS, Cook RS, et al. Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori. Gut 1991;32:467-9.
19. Ruiz B, Janney A, Diavolitsis S, et al. One-minute test for Campylobacter pylori. Am J Gastroenterol 1989;84:202.
20. Lerang F, Moum B, Ragnhildstveit E, et al. Helicobacter pylori (HP) infection and metronidazole (MTZ) resistance. Gut 1995;37(suppl 1):A86.
21. Xia H, Daw MA, Sant S, et al. Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer. Eur J Gastroenterol Hepatol 1993;5:141-4.
22. Bell GD, Powell K, Burridge SM, et al. Experience with "triple" anti-Helicobacter pylori eradication therapy: Side effects and importance of testing the pretreatment isolate for metronidazole resistance. Aliment Pharmacol Ther 1992;6:427-35.
23. Hirschl AM, Hirschl MM, Rotter ML. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J Antimicrob Chemother 1993;32:45-9.
24. Cederbrant G, Kahlmeter G, Ljungh Å. Proposed mechanism for metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 1992;29:115-20.
25. van Zwet AA, Thijs JC, de Graaf B. Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains. Antimicrob Agents Chemother 1995;39:250-2.
26. van Caekenberghe DI, Breyssens J. In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori). Antimicrob Agents Chemother 1987;31:1429-30.
27. Gustavsson LE, Kaiser JF, Edmonds AL, et al. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 1995;39:2078-83.
28. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of H. pylori: A randomized, double-blind trial. Am J Gastroenterol 1993;88:1860-4.
29. Cayla R, Zerbib F, Talbi P, et al. Pre and post-treatment claritromycin resistance of Helicobacter pylori strains: A key factor of treatment failure. Gut 1995;37(suppl 1):A55.
30. de Boer WA, Thys JC, Borody TJ, et al. Proposal for use of a standard side effect scoring system in studies exploring H. pylori treatment regimens. Eur J Gastroenterol Hepatol 1996;8:641-3.
31. Brown KE, Peura DA. In diagnosis of Helicobacter pylori infection. Gastroenterol Clin North Am 1993;22:105-15.
32. van Zwet AA, Thijs JC, Kooistra-Smid AM, et al. Sensitivity of culture compared with that of polymerase chain reaction for detection of Helicobacter pylori from antral biopsy samples. J Clin Microbiol 1993;31:1918-20.
33. Siepman N, Green R, Aynilian G. A comparison of biopsy specimens from the antrum and corpus for culture of H. pylori. Gut 1995;37(suppl 2):A81.